These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 28471194

  • 1. [Lactate Dehydrogenase - Old Tumour Marker in the Light of Current Knowledge and Preanalytic Conditions].
    Greplová K, Selingerová I, Valík D, Pilatova K, Češková M, Zdražilová Dubská L.
    Klin Onkol; 2017; 30(Supplementum1):156-158. PubMed ID: 28471194
    [Abstract] [Full Text] [Related]

  • 2. [Circulating Myeloid Suppressor Cells and Their Role in Tumour Immunology].
    Pilatova K, Budinská E, Bensciková B, Nenutil R, Šefr R, Fedorová L, Hanáková B, Brychtová V, Zdražilová Dubská L.
    Klin Onkol; 2017; 30(Supplementum1):166-169. PubMed ID: 28471197
    [Abstract] [Full Text] [Related]

  • 3. Lactic Dehydrogenase in the In Vitro Evaluation of Hemolytic Properties of Ventricular Assist Device.
    Li D, Wu Q, Liu S, Chen Y, Chen H, Ruan Y, Zhang Y.
    Artif Organs; 2017 Nov; 41(11):E274-E284. PubMed ID: 28722142
    [Abstract] [Full Text] [Related]

  • 4. Discriminatory performance of positive urine hemoglobin for detection of significant hemolysis in patients with continuous-flow left ventricular assist devices.
    Gavalas MV, Breskin A, Yuzefpolskaya M, Eisenberger A, Castagna F, Demmer RT, Flannery M, Garan AR, Takeda K, Takayama H, Naka Y, Topkara VK, Colombo PC.
    J Heart Lung Transplant; 2017 Jan; 36(1):59-63. PubMed ID: 27773451
    [Abstract] [Full Text] [Related]

  • 5. Falsely Increased Plasma Lactate Dehydrogenase without Hemolysis Following Transport through Pneumatic Tube System.
    Herman DS, Toro E, Baraban EG, Bagg A, Wang P.
    J Appl Lab Med; 2019 Nov; 4(3):433-438. PubMed ID: 31659082
    [Abstract] [Full Text] [Related]

  • 6. Overall survival of cancer patients with serum lactate dehydrogenase greater than 1000 IU/L.
    Liu R, Cao J, Gao X, Zhang J, Wang L, Wang B, Guo L, Hu X, Wang Z.
    Tumour Biol; 2016 Oct; 37(10):14083-14088. PubMed ID: 27511116
    [Abstract] [Full Text] [Related]

  • 7. Hemoglobin interference from in vivo hemolysis.
    Blank DW, Kroll MH, Ruddel ME, Elin RJ.
    Clin Chem; 1985 Sep; 31(9):1566-9. PubMed ID: 4028407
    [Abstract] [Full Text] [Related]

  • 8. Hemolysis: a harbinger of adverse outcome after left ventricular assist device implant.
    Cowger JA, Romano MA, Shah P, Shah N, Mehta V, Haft JW, Aaronson KD, Pagani FD.
    J Heart Lung Transplant; 2014 Jan; 33(1):35-43. PubMed ID: 24418732
    [Abstract] [Full Text] [Related]

  • 9. Elimination of hemoglobin and lactate dehydrogenase from plasma in normals and patients with intravascular hemolysis.
    Dale J, Myhre E, Rasmussen K.
    Scand J Clin Lab Invest; 1972 Jan; 29(4):389-95. PubMed ID: 21488405
    [Abstract] [Full Text] [Related]

  • 10. Lactate dehydrogenase as a biomarker of hemolysis-associated nitric oxide resistance, priapism, leg ulceration, pulmonary hypertension, and death in patients with sickle cell disease.
    Kato GJ, McGowan V, Machado RF, Little JA, Taylor J, Morris CR, Nichols JS, Wang X, Poljakovic M, Morris SM, Gladwin MT.
    Blood; 2006 Mar 15; 107(6):2279-85. PubMed ID: 16291595
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Current Methods of microRNA Analysis.
    Bartošík M, Jiráková L.
    Klin Onkol; 2018 Mar 15; 31(Suppl 2):93-101. PubMed ID: 31023031
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Prognostic importance of lactate dehydrogenase (LDH) in oncology].
    Deme D, Telekes A.
    Orv Hetil; 2017 Dec 15; 158(50):1977-1988. PubMed ID: 29226713
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Proteogenomic Platform for Identification of Tumor Specific Antigens.
    Faktor J, Hernychová L, Vojtěšek B, Hupp T.
    Klin Onkol; 2018 Dec 15; 31(Suppl 2):102-107. PubMed ID: 31023032
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. High serum lactate dehydrogenase level as a marker for drug resistance and short survival in multiple myeloma.
    Dimopoulos MA, Barlogie B, Smith TL, Alexanian R.
    Ann Intern Med; 1991 Dec 15; 115(12):931-5. PubMed ID: 1952489
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.